WEST PHARMACEUTICAL SERVICES overview

West to Participate in Upcoming Investor Conferences PR Newswire EXTON, Pa., March 5, 2025 EXTON, Pa. , March 5, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Barclays 27th Annual Global Healthcare Conference on Wednesday, March 12, 2025 at 11:00 AM ET . It will also present at the KBCM Healthcare Forum on Wednesday, March 19, 2025 at 1:30 PM ET. A live...

West Announces Second-Quarter Dividend PR Newswire EXTON, Pa., Feb. 20, 2025 EXTON, Pa. , Feb. 20 , 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a second-quarter 2025 dividend of $0.21 per share. The dividend will be paid on May 7, 2025 , to shareholders of record as of April 30, 2025 . About West West Pharmaceutical Services, Inc....

West Announces Fourth-Quarter and Full-Year 2024 Results PR Newswire EXTON, Pa., Feb. 13, 2025 - Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , Feb. 13, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2024 and introduced 2025 financial guidance. Fourth-Quarter Summary (comparisons to prior-year period) & Full-Year 2025 Guidance Fourth-quarter 2024 net sales of $748.8 million increased...

West to Host Fourth-Quarter and Full-Year 2024 Conference Call PR Newswire EXTON, Pa., Jan. 30, 2025 EXTON, Pa. , Jan. 30 , 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2024 financial results before the market opens on Thursday, February 13, 2025, and will follow with a conference call to discuss the results and business expectations...

West Announces First-Quarter Dividend PR Newswire EXTON, Pa., Jan. 28, 2025 EXTON, Pa. , Jan. 28, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a first-quarter 2025 dividend of $0.21 per share. The dividend will be paid on February 11, 2025, to shareholders of record as of February 7, 2025. About West West Pharmaceutical Services,...

West Introduces Daikyo PLASCAP® RUV Closures in New Nested Format at Pharmapack PR Newswire EXTON, Pa., Jan. 22, 2025 EXTON, Pa. , Jan. 22, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the introduction of Daikyo PLASCAP® Ready-to-Use Validated (RUV) closures in a new nested format available in multiple configurations at this year's Pharmapack event in Paris , France. This marks...

West Pharmaceutical Services to Present at the CJS 25th Annual "New Ideas for the New Year" Investor Conference PR Newswire EXTON, Pa., Jan. 6, 2025 EXTON, Pa. , Jan. 6, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that Cindy Reiss-Clark , Sr. VP and Chief Commercial Officer; Chad Winters , VP of Finance and Chief Accounting Officer; and John Sweeney , VP of Investor Relations,...

West Elects New Director to the Board PR Newswire EXTON, Pa., Dec. 11, 2024 EXTON, Pa. , Dec. 11, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's Board of Directors has elected Janet Haugen as its newest member. With the addition of Ms. Haugen, West's Board has 12 directors. Ms. Haugen, 66, is the former Chief Financial Officer of Unisys Corporation, a role she served in...